<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02804451</url>
  </required_header>
  <id_info>
    <org_study_id>03/02/2016</org_study_id>
    <nct_id>NCT02804451</nct_id>
  </id_info>
  <brief_title>Intubation During Cardiopulmonary Resuscitation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to compare the intubation time and effectiveness, the grade of
      larynx visibility, and the ease of intubation in adults performed by nurses using 4 devices:
      a Macintosh blade laryngoscope (MAC), and a TruView EVO2 (EVO2), TruView EVO2 PCD (PCD), and
      ETView SL (ETView) laryngoscope, in simulated CPR settings with and without CC.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to the first ventilation attempt</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to visualize the larynx</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to introduce the endotracheal tube through the vocal cords</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>success rate</measure>
    <time_frame>1 day</time_frame>
    <description>first intubation attempt success rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>degree of larynx visibility</measure>
    <time_frame>1 day</time_frame>
    <description>analysed based on a Cormack-Lehane scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ease of intubation technique</measure>
    <time_frame>1 day</time_frame>
    <description>10-point visual analogue scale (VAS) was used, where 1 indicated an extremely simple procedure, while 10 - an extremely difficult one</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Endotracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Intubation without chest compression</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>normal airway, without chest compression during intubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intubation with uninterrupted chest compression</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>normal airway, with continuous chest compressions</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Macintosh laryngoscope</intervention_name>
    <description>intubation with standard macintosh larygoscope; gold standard</description>
    <arm_group_label>Intubation without chest compression</arm_group_label>
    <arm_group_label>Intubation with uninterrupted chest compression</arm_group_label>
    <other_name>MAC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TruView EVO2 laryngoscope</intervention_name>
    <description>A TruView EVO2 laryngoscope with blade size 3 (EVO2; Truphatek Holdings, Ltd., Netanya, Israel),</description>
    <arm_group_label>Intubation without chest compression</arm_group_label>
    <arm_group_label>Intubation with uninterrupted chest compression</arm_group_label>
    <other_name>EVO2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TruView EVO2 PCD laryngoscope</intervention_name>
    <description>A TruView EVO2 PCD laryngoscope with blade size 3 (PCD; Truphatek Interbational Ltd., Netanya, Israel),</description>
    <arm_group_label>Intubation without chest compression</arm_group_label>
    <arm_group_label>Intubation with uninterrupted chest compression</arm_group_label>
    <other_name>PCD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ETView SL</intervention_name>
    <description>An ETView SL (ETView; ETViewLtd, Misgav, Israel) ednotracheal tube</description>
    <arm_group_label>Intubation without chest compression</arm_group_label>
    <arm_group_label>Intubation with uninterrupted chest compression</arm_group_label>
    <other_name>ETView</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  had not received any training in endotracheal intubation with videolaryngoscopy before
             the study,

          -  had nursing specialization in anaesthesiology or emergency medicine,

          -  presented with no wrist or low back diseases or pregnancy.

        Exclusion Criteria:

          -  not meet the above criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukasz Szarpak, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Warsaw, Department of Emergency Medicine</name>
      <address>
        <city>Warsaw</city>
        <state>Masovia</state>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Kurowski A, Szarpak L, Truszewski Z, Czyzewski L. Can the ETView VivaSight SL Rival Conventional Intubation Using the Macintosh Laryngoscope During Adult Resuscitation by Novice Physicians?: A Randomized Crossover Manikin Study. Medicine (Baltimore). 2015 May;94(21):e850. doi: 10.1097/MD.0000000000000850. Erratum in: Medicine (Baltimore). 2015 Jun;94(25):1.</citation>
    <PMID>26020389</PMID>
  </reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>June 14, 2016</last_update_submitted>
  <last_update_submitted_qc>June 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>≈Åukasz Szarpak</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

